Literature DB >> 35554902

Detection and Quantification of SARS-CoV-2 by Real-Time RT-PCR Assay.

Alexander Wilhelm1,2, Christiane Pallas1, Rolf Marschalek2, Marek Widera3.   

Abstract

The pandemic coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread and high mortality rate. Detection and quantification of the (+) ssRNA virus, which has a genome size of 29,903 nucleotides, is commonly performed via reverse transcription quantitative polymerase chain reaction (RT-qPCR) targeting conserved sequences. Here, we describe a one-step RT-qPCR protocol for the quantitative detection of SARS-CoV-2 genomic RNA targeting M and RdRP genes, respectively, as well as active virus replication detecting subgenomic RNAs (sgRNA 4 and 8) that are formed by discontinuous transcription of the viral genome. Concomitantly, an input control targeting the human RNaseP gene (RPP30) was used in multiplex PCR to monitor the input of human nucleic acids. In vitro-transcribed RNA harboring the amplicon regions for M and RdRP regions served to set up a standard curve for absolute quantification.In conclusion, the method described here allows for the detection and quantification of SARS-CoV-2 RNA isoforms for research by both using a probe-based or SYBR Green-based approach, but is also suitable for diagnostic purposes.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  COVID-19; RdRP; Real time polymerase chain reaction; Reverse transcription; SARS-CoV-2

Mesh:

Substances:

Year:  2022        PMID: 35554902     DOI: 10.1007/978-1-0716-2111-0_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR.

Authors:  Hyun-Wook Rho; Byoung-Chan Lee; Eun-Seok Choi; Il-Ju Choi; Yeon-Su Lee; Sung-Ho Goh
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

3.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

4.  Selection of reference genes for gene expression studies in human neutrophils by real-time PCR.

Authors:  Xiaozhu Zhang; Lily Ding; Andrew J Sandford
Journal:  BMC Mol Biol       Date:  2005-02-18       Impact factor: 2.946

5.  Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.

Authors:  Donghyuk Shin; Rukmini Mukherjee; Diana Grewe; Denisa Bojkova; Kheewoong Baek; Anshu Bhattacharya; Laura Schulz; Marek Widera; Ahmad Reza Mehdipour; Georg Tascher; Paul P Geurink; Alexander Wilhelm; Gerbrand J van der Heden van Noort; Huib Ovaa; Stefan Müller; Klaus-Peter Knobeloch; Krishnaraj Rajalingam; Brenda A Schulman; Jindrich Cinatl; Gerhard Hummer; Sandra Ciesek; Ivan Dikic
Journal:  Nature       Date:  2020-07-29       Impact factor: 49.962

6.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

7.  The Architecture of SARS-CoV-2 Transcriptome.

Authors:  Dongwan Kim; Joo-Yeon Lee; Jeong-Sun Yang; Jun Won Kim; V Narry Kim; Hyeshik Chang
Journal:  Cell       Date:  2020-04-23       Impact factor: 41.582

8.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.